Literature DB >> 28446986

Sublobar resection for stage IA non-small cell lung cancer.

Kathleen S Berfield1, Douglas E Wood1.   

Abstract

Advancements in the diagnosis, staging and management of lung cancer have all led to improvements in outcomes associated with sublobar resection. Lobectomy, for early stage lung cancers has been the treatment of choice for many years. However, there is mounting evidence that sublobar resection when applied to the appropriate patient population can provide not only excellent oncologic results but also equivalent survival to lobectomy. Therefore, it is time that we reevaluate the management of peripheral stage IA lung cancers.

Entities:  

Keywords:  Lung cancer; lobectomy; stage IA lung cancer; sublobar resection

Year:  2017        PMID: 28446986      PMCID: PMC5392547          DOI: 10.21037/jtd.2017.03.135

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  8 in total

1.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

Review 2.  Meta-analysis of intentional sublobar resections versus lobectomy for early stage non-small cell lung cancer.

Authors:  Christopher Cao; Sunil Gupta; David Chandrakumar; David H Tian; Deborah Black; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2014-03

3.  Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study.

Authors:  Morihito Okada; Teruaki Koike; Masahiko Higashiyama; Yasushi Yamato; Ken Kodama; Noriaki Tsubota
Journal:  J Thorac Cardiovasc Surg       Date:  2006-10       Impact factor: 5.209

4.  Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.

Authors:  Amgad El-Sherif; William E Gooding; Ricardo Santos; Brian Pettiford; Peter F Ferson; Hiran C Fernando; Susan J Urda; James D Luketich; Rodney J Landreneau
Journal:  Ann Thorac Surg       Date:  2006-08       Impact factor: 4.330

5.  Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.

Authors:  Nasser K Altorki; Rowena Yip; Takaomi Hanaoka; Thomas Bauer; Ralph Aye; Leslie Kohman; Barry Sheppard; Richard Thurer; Shahriyour Andaz; Michael Smith; William Mayfield; Fred Grannis; Robert Korst; Harvey Pass; Michaela Straznicka; Raja Flores; Claudia I Henschke
Journal:  J Thorac Cardiovasc Surg       Date:  2013-11-23       Impact factor: 5.209

6.  Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.

Authors:  Yasuhiro Tsutani; Yoshihiro Miyata; Haruhiko Nakayama; Sakae Okumura; Shuji Adachi; Masahiro Yoshimura; Morihito Okada
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

7.  Temporal trends in outcomes following sublobar and lobar resections for small (≤ 2 cm) non-small cell lung cancers--a Surveillance Epidemiology End Results database analysis.

Authors:  Sai Yendamuri; Rohit Sharma; Michael Demmy; Adrienne Groman; Mark Hennon; Elisabeth Dexter; Chukwumere Nwogu; Austin Miller; Todd Demmy
Journal:  J Surg Res       Date:  2012-12-20       Impact factor: 2.192

8.  Segmentectomy versus wedge resection for the treatment of high-risk operable patients with stage I non-small cell lung cancer: a meta-analysis.

Authors:  Bing Hou; Xu-Feng Deng; Dong Zhou; Quan-Xing Liu; Ji-Gang Dai
Journal:  Ther Adv Respir Dis       Date:  2016-09-01       Impact factor: 4.031

  8 in total
  11 in total

1.  Stereotactic body radiotherapy for operable, early stage non-small cell lung cancer-let's all take a deep breath.

Authors:  Eric B Howell; Kathleen S Berfield; Douglas E Wood
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Taking the measure of lung adenocarcinoma: towards a quantitative approach to tumor spread through air spaces (STAS).

Authors:  Vicente Morales-Oyarvide; Mari Mino-Kenudson
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

3.  A CT-based logistic regression model to predict spread through air space in lung adenocarcinoma.

Authors:  Chuanjun Li; Changsi Jiang; Jingshan Gong; Xiaotao Wu; Yan Luo; Guopin Sun
Journal:  Quant Imaging Med Surg       Date:  2020-10

4.  ARTIS Pheno®-the future of thoracic hybrid theatre for lung nodule resection?

Authors:  Joyce W Y Chan; Peter S Y Yu; Rainbow W H Lau; Calvin S H Ng
Journal:  J Thorac Dis       Date:  2020-09       Impact factor: 2.895

5.  Low-dose indocyanine green fluorescence-navigated segmentectomy: prospective analysis of 20 cases and review of previous reports.

Authors:  Nozomu Motono; Shun Iwai; Aika Funasaki; Atsushi Sekimura; Katsuo Usuda; Hidetaka Uramoto
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

Review 6.  [Progress on the Study of Tumor Spread Through Air Spaces in the Clinicopathological Characteristics of Lung Adenocarcinoma and Its Influence on the Surgical Treatment and Prognosis of Lung Cancer].

Authors:  Guidong Qu; Yunfei Shi
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2019-06-20

7.  Segmental resection is associated with decreased survival in patients with stage IA non-small cell lung cancer with a tumor size of 21-30 mm.

Authors:  Xiangyang Yu; Rusi Zhang; Mengqi Zhang; Yongbin Lin; Xuewen Zhang; Yingsheng Wen; Longjun Yang; Zirui Huang; Gongming Wang; Dechang Zhao; Michel Gonzalez; Jean-Marc Baste; Rene Horsleben Petersen; Calvin S H Ng; Alessandro Brunelli; Lie Zheng; Lanjun Zhang
Journal:  Transl Lung Cancer Res       Date:  2021-02

8.  Comparison of surgical outcomes and prognosis between wedge resection and simple Segmentectomy for GGO diameter between 2 cm and 3 cm in non-small cell lung cancer: a multicenter and propensity score matching analysis.

Authors:  Yaodong Zhou; Tao Yu; Yixin Zhang; Liqiang Qian; Qing Xia
Journal:  BMC Cancer       Date:  2022-01-16       Impact factor: 4.430

9.  Interstitial lung disease and wedge resection are poor prognostic factors for non-small cell lung cancer.

Authors:  Nozomu Motono; Masahito Ishikawa; Shun Iwai; Yoshihito Iijima; Hidetaka Uramoto
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

10.  Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.

Authors:  Yue Yu; Renhong Huang; Pei Wang; Suyu Wang; Xinyu Ling; Peng Zhang; Jingwen Yu; Jun Wang; Jian Xiao; Zhinong Wang
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.